Real-world clinical outcomes of cabozantinib as a second-line treatment for advanced hepatocellular carcinoma: a retrospective US claims analysis. - Ahn DH; Park NJ; Locker M; Zhou ZY; Nie X; Wang T; Yu S (The oncologist, 2025)